Authors:
Aninat, C
Hayashi, Y
Andre, F
Delaforge, M
Citation: C. Aninat et al., Molecular requirements for inhibition of cytochrome P450 activities by roquefortine, CHEM RES T, 14(9), 2001, pp. 1259-1265
Authors:
Vadon-Le Goff, S
Delaforge, M
Boucher, JL
Janosik, M
Kraus, JP
Mansuy, D
Citation: S. Vadon-le Goff et al., Coordination chemistry of the heme in cystathionine beta-synthase: Formation of iron(II)-isonitrile complexes, BIOC BIOP R, 283(2), 2001, pp. 487-492
Citation: M. Delaforge et al., Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D, ENV TOX PH, 7(3), 1999, pp. 153-158
Authors:
Roch-Arveiller, M
Fontagne, J
Coudray-Lucas, C
Le Boucher, J
Cynober, L
Muntaner, O
Delaforge, M
Citation: M. Roch-arveiller et al., Ornithine alpha-ketoglutarate counteracts the decrease of liver cytochromeP-450 content in burned rats, NUTRITION, 15(5), 1999, pp. 379-383
Authors:
Gharbi-Benarous, J
Evrard-Todeschi, N
Ladam, P
Bertho, G
Delaforge, M
Girault, JP
Citation: J. Gharbi-benarous et al., Conformational analysis of josamycin, a 16-membered macrolide free in solution and bound to bacterial ribosomes, J CHEM S P2, (3), 1999, pp. 529-543
Authors:
Rouaud, C
Delaforge, M
Anger-Leroy, M
Le Filliatre, G
Finet, M
Hanf, R
Citation: C. Rouaud et al., The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E-2-mediated relaxation, BR J PHARM, 126(1), 1999, pp. 35-44